Zobrazeno 1 - 6
of 6
pro vyhledávání: '"James Froeschle"'
Publikováno v:
The Pediatric Infectious Disease Journal. 23:429-435
Young children have the highest incidence of meningococcal infection. Approximately 50% of disease in United States children less than 2 years of age is caused by serogroups C and Y. In the developing world, serogroups A and W-135 cause outbreaks and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d08b64e67fbc2ae491197c08c8f82c4
https://doi.org/10.1097/01.inf.0000126297.28952.f8
https://doi.org/10.1097/01.inf.0000126297.28952.f8
Autor:
Bernd H. Belohradsky, Sarah Jow, Andreas Kronwitter, Thomas H. Zink, Johannes G. Liese, James Froeschle, Erika Harzer, Robert Klepadlo, S. Stojanov
Publikováno v:
The Pediatric Infectious Disease Journal. 20:981-988
Objectives.To evaluate the safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid (Biken DTaP) vaccine administered to children 4 to 6 years of age who had previously received four doses of Bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65b862e35720943c82eb59ecf034c8fc
https://doi.org/10.1097/00006454-200110000-00012
https://doi.org/10.1097/00006454-200110000-00012
Publikováno v:
Journal of travel medicine. 11(4)
Although human diploid cell vaccine (HDCV) has been available for over two decades and has a proven record of efficacy, it is very expensive to produce and can only be made in small quantities.In this trial, we compared the safety and immunogenicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::55f1031dfe49fb17e83d1c3bc09acbd3
https://pubmed.ncbi.nlm.nih.gov/15541220
https://pubmed.ncbi.nlm.nih.gov/15541220
Autor:
James King, Margaret B. Rennels, Ryall Robert P, James Froeschle, Susan Manoff, Thomas Papa, Andrea Weddle
Publikováno v:
The Pediatric infectious disease journal. 21(10)
Two injections of tetravalent (Groups A, C, Y and W-135) meningococcal polysaccharide vaccine conjugated to diphtheria were given to 30 toddlers at dosages of 1, 4 and 10 microg/ml polysaccharide of each serogroup. Reactogenicity was acceptable at al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::550f157a7be22ea198b4e4e9119be841
https://pubmed.ncbi.nlm.nih.gov/12400528
https://pubmed.ncbi.nlm.nih.gov/12400528
Publikováno v:
The Pediatric infectious disease journal. 21(8)
Since 1997 diphtheria-tetanus toxoids-acellular pertussis (DTaP) vaccines have been recommended for the five dose pertussis vaccination series. To assess rates of medically attended injection site reactions (ISRs), seizures, allergic responses and fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb30a7bf1dc3d0662875878dc017d9a7
https://pubmed.ncbi.nlm.nih.gov/12192169
https://pubmed.ncbi.nlm.nih.gov/12192169
Autor:
S. Stojanov, Carlton Meschievitz, Frank Porter, James Froeschle, Phil Hosbach, Jörg E. Hoppe, Kii Niinivaara, Johannes G. Liese, Bernd H. Belohradsky, Erika Harzer, Alexander M. Walker
Publikováno v:
The Pediatric infectious disease journal. 16(11)
This case-control study investigated the protective efficacy against pertussis of three doses of a two-component acellular pertussis vaccine (manufactured by Biken in Japan) combined with diphtheria and tetanus toxoids (manufactured by Connaught Labo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de9b73d2aa51f30bb20346d873ed2b59
https://pubmed.ncbi.nlm.nih.gov/9384336
https://pubmed.ncbi.nlm.nih.gov/9384336